Patent Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen

Basic data

Title:
Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
Reference number (DPMA):
10 2004 042 894.8
Primary registration:
30/08/2004
Abandoment:
01/03/2017 (expired)

Inventors

Faculty of Medicine
University of Tübingen

Local organizational units

Faculty of Medicine
University of Tübingen

National patents

PCT Registration

Registration date:
08/08/2005
Registration number:
PCT/EP2005/008579

Nationalizations

Patent familiy:
10 2004 042 894.8, EP05773900

EP05773900
European Patent Office
08/08/2005
03/03/2017 (expired)
Help

will be deleted permanently. This cannot be undone.